These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38796274)

  • 21. Systemic glucocorticoid use and the occurrence of flares in psoriatic arthritis and psoriasis: a systematic review.
    Vincken NLA; Balak DMW; Knulst AC; Welsing PMJ; van Laar JM
    Rheumatology (Oxford); 2022 Nov; 61(11):4232-4244. PubMed ID: 35285486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment use and satisfaction among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
    Tveit KS; Duvetorp A; Østergaard M; Skov L; Danielsen K; Iversen L; Seifert O
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):340-354. PubMed ID: 30242921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.
    Jadon DR; Sengupta R; Nightingale A; Lu H; Dunphy J; Green A; Elder JT; Nair RP; Korendowych E; Lindsay MA; McHugh NJ
    Arthritis Res Ther; 2017 Sep; 19(1):210. PubMed ID: 28934972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease.
    Solmaz D; Bakirci S; Kimyon G; Gunal EK; Dogru A; Bayindir O; Dalkilic E; Ozisler C; Can M; Akar S; Cetin GY; Yavuz S; Kilic L; Tarhan EF; Kucuksahin O; Omma A; Gonullu E; Yildiz F; Ersozlu ED; Cinar M; Al-Onazi A; Erden A; Tufan MA; Yilmaz S; Pehlevan S; Kalyoncu U; Aydin SZ
    Arthritis Care Res (Hoboken); 2020 Jan; 72(1):63-68. PubMed ID: 30680951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires.
    Shin D; Kim HJ; Kim DS; Kim SM; Park JS; Park YB; Lee MG
    Rheumatol Int; 2016 Feb; 36(2):207-12. PubMed ID: 26395992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.
    Lebwohl MG; Kavanaugh A; Armstrong AW; Van Voorhees AS
    Am J Clin Dermatol; 2016 Feb; 17(1):87-97. PubMed ID: 26718712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis.
    Wu JJ; Pelletier C; Ung B; Tian M; Khilfeh I; Curtis JR
    Adv Ther; 2020 May; 37(5):2098-2115. PubMed ID: 32141018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.
    López Estebaránz JL; Zarco-Montejo P; Samaniego ML; García-Calvo C;
    Eur J Dermatol; 2015; 25(1):57-63. PubMed ID: 25333645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis.
    Viguier M; Richette P; Aubin F; Beylot-Barry M; Lahfa M; Bedane C; Delesalle F; Richard-Lallemand MA; Delaporte E; Dubertret L; Bardin T; Bachelez H
    Arthritis Rheum; 2008 Jun; 58(6):1796-802. PubMed ID: 18512820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.
    Feist E; Baraliakos X; Behrens F; Thaçi D; Plenske A; Klaus P; Meng T
    Rheumatol Ther; 2024 Apr; 11(2):331-348. PubMed ID: 38308727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database.
    Merola JF; Patil D; Egana A; Steffens A; Webb NS; Gottlieb AB
    Dermatol Ther (Heidelb); 2023 Nov; 13(11):2635-2648. PubMed ID: 37726542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?
    Megna M; Ocampo-Garza SS; Potestio L; Fontanella G; Gallo L; Cacciapuoti S; Ruggiero A; Fabbrocini G
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
    Duvetorp A; Østergaard M; Skov L; Seifert O; Tveit KS; Danielsen K; Iversen L
    Arch Dermatol Res; 2019 Jul; 311(5):351-360. PubMed ID: 30868221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis.
    Gisondi P; Bellinato F; Targher G; Idolazzi L; Girolomoni G
    Ann Rheum Dis; 2022 Jan; 81(1):68-73. PubMed ID: 34144965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies.
    Raychaudhuri SP; Wilken R; Sukhov AC; Raychaudhuri SK; Maverakis E
    J Autoimmun; 2017 Jan; 76():21-37. PubMed ID: 27836567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?
    Abji F; Lee KA; Pollock RA; Machhar R; Cook RJ; Chandran V; Gladman DD
    Br J Dermatol; 2020 Nov; 183(5):920-927. PubMed ID: 32037514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis.
    Skornicki M; Prince P; Suruki R; Lee E; Louder A
    Adv Ther; 2021 May; 38(5):2458-2471. PubMed ID: 33818686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention.
    Zabotti A; Tinazzi I; Aydin SZ; McGonagle D
    Curr Rheumatol Rep; 2020 May; 22(6):24. PubMed ID: 32418006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.